Drug Eruptions Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market

November 30 22:50 2022
Drug Eruptions Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the Market
DelveInsight Business Research LLP
DelveInsight’s “Drug Eruptions Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Drug Eruptions, historical and forecasted epidemiology as well as the Drug Eruptions market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight’s “Drug Eruptions Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Drug Eruptions, historical and forecasted epidemiology as well as the Drug Eruptions market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Drug Eruptions market report provides current treatment practices, emerging drugs, Drug Eruptions market share of the individual therapies, and current and forecasted Drug Eruptions market size from 2019 to 2032 segmented by seven major markets. The Report also covers current Drug Eruptions treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Drug Eruptions Overview

Acute or subacute adverse cutaneous reactions to a drug or medicine include drug eruptions. There are many types of drug eruption, which range from a clinically mild and unnoticed rash to a severe cutaneous adverse reaction (SCAR) that may be life-threatening. The most common drug eruptions are Morbilliform or exanthematous drug eruption angioedema (which rarely leads to anaphylaxis). Acute or subacute adverse cutaneous reactions to a drug or medicine include drug eruptions. There are many types of drug eruption, which range from a clinically mild and unnoticed rash to a severe cutaneous adverse reaction (SCAR) that may be life-threatening.

Drug Eruptions Epidemiology Insights:

  • Studies on Drug Eruptions, have provided important information on the type of reaction and the potentially causative drug but were not designed to investigate the incidence and prevalence of the reactions, which could therefore only be roughly estimated. 

  • Recently, two prospective trials on the epidemiology of drug eruption hospitals were carried out. The first (French) study analyzed cADRs after systemic intake or application of drugs in a specific hospital over a period of 6 months. All patients were examined by a dermatologist, and the drug use was evaluated by a pharmacologist. 

  • Based on 48 hospitalized patients in whom drug eruptions were diagnosed, a prevalence of 3.6 per 1,000 hospitalized patients was calculated. The second study was a prospective cohort study carried out in Mexico over a period of 10 months. 

  • This study demonstrated a prevalence of 7 per 1,000 hospitalized patients. In South Korea, a mandatory electronic reporting system for immunologically mediated drug eruptions could identify 2,652 cases of ADR in a total of 55,432 hospitalizations over a period of 7 months. 

  • The study included cutaneous as well as non-cutaneous reactions. An allergist classified 532 reactions to be “significant drug hypersensitivity reactions”. 100 of these were new events, and 70% of them had a cutaneous manifestation. The overall incidence of ADRs was estimated to be 1.8 per 1,000 hospitalizations.

Drug Eruptions Epidemiology Segmentation

 

  • Total Drug Eruptions patient segmentation 

  • Total  Drug Eruptions risk factors 

  • Total Drug Eruptions diagnostic cases 

  • Total Drug Eruptions treatment cases 

  • Total Drug Eruptions growth-related factors observed in patients 

Drug Eruptions Market Outlook 

The Drug Eruptions market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Drug Eruptions market trends by analyzing the impact of current Drug Eruptions therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Drug Eruptions market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Drug Eruptions market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

 

According to DelveInsight, the Drug Eruptions market in 7MM is expected to witness a major change in the study period 2019-2032.

Learn more by requesting for sample @ Drug Eruptions Market Trends

 Drug Eruptions Key Companies 

  • Merck 

  • Pfizer

  • Bayer

  • Roch 

  • GSK

  • And many others 

 

Table of Contents

 

  1.  Key Insights 

  2.  Report Introduction 

  3.  Executive Summary of Drug Eruptions

  4.  Disease Background and Overview

  5.  Epidemiology and patient population

  6.  The United States 

  7.  EU 5

  8.  Drug Eruptions  Emerging Therapies

  9.  Drug Eruptions Market Outlook

  10.  Market Access and Reimbursement of Therapies

  11.  Market Drivers 

  12.  Market Barriers 

  13.  Appendix

  14.  Drug Eruptions Report Methodology

  15.  DelveInsight Capabilities

  16.  Disclaimer

Click here to read more about Drug Eruptions Market Trends

Media Contact
Company Name: DelveInsight
Contact Person: Adya Kaul
Email: Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/